Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Rx Import Task Force Will Hold Public Hearings, Meet With Stakeholders

This article was originally published in The Pink Sheet Daily

Executive Summary

The group will hold five meetings with stakeholders, including industry associations. Members are yet to be named, but will include representatives from several federal agencies.

You may also be interested in...



FDA Rx Import Task Force Will Hold Inaugural Stakeholder Meeting March 19

The group's first meeting will be with consumer organizations. FDA Commissioner McClellan is no longer chairing the task force, HHS Secretary Thompson announces.

FDA Rx Import Task Force Will Hold Inaugural Stakeholder Meeting March 19

The group's first meeting will be with consumer organizations. FDA Commissioner McClellan is no longer chairing the task force, HHS Secretary Thompson announces.

CMS Nominee McClellan Says He Will Testify On Rx Imports, But May Still Face Confirmation Delay

FDA Commissioner McClellan tells the Senate Finance Committee he will testify about drug reimportation after his nomination to head the Centers for Medicare & Medicaid Services is approved by the Senate. Sen. Dorgan, who has threatened to place a "hold" on the vote, is understood to be unwilling to wait.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058709

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel